Company Search:
Advanced Search
Sponsored Links
3sbio Inc Company Snapshot
3sbio Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares 3sbio Inc with three other companies in this sector in CHINA : Luoxin Pharmaceuticals Group Stock Co Ltd (2020 sales of 6.10 billion Chinese Renmimbi [US$944.69 million] of which 63% was Pharmaceutical industry), Guizhou Xinbang Pharmaceutical Company Limited (5.85 billion Chinese Renmimbi [US$905.90 million] of which 83% was Pharmaceutical industry), and Zhejiang Conba Pharmaceutical Co., Ltd. (5.91 billion Chinese Renmimbi [US$915.49 million] of which 96% was Jiangsu, Zhejiang and Shanghai Branch).

Sales Analysis. 3sbio Inc reported sales of 5.59 billion Chinese Renmimbi (US$865.92 million) for the year ending December of 2020. This represents an increase of 5.1% versus 2019, when the company's sales were 5.32 billion Chinese Renmimbi. Sales at 3sbio Inc have increased during each of the previous five years (and since 2015, sales have increased a total of 234%). Sales of Biopharmaceuticals saw an increase of 4.9% in 2020, from 5.29 billion Chinese Renmimbi to 5.55 billion Chinese Renmimbi. Not all segments of 3sbio Inc experienced an increase in sales in 2020: sales of Technical Service fell 59.7% to 10.35 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
3sbio Inc
  Stock Performance Chart for 3sbio Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/18/2021): 9.14
(Figures in Chinese Renmimbi)
1 Week 5.4%   13 Weeks 42.2%  
4 Weeks 48.4%   52 Weeks -1.4%  
3sbio Inc Key Data:
  Ticker: 1530 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 5,587,636,000
(Year Ending Jan 2021).
Employees: 5,584
  Currency: Chinese Renmimbi Market Cap: 23,255,075,621
  Fiscal Yr Ends: December Shares Outstanding: 2,543,600,999
  Share Type: Ordinary Closely Held Shares: 1,093,260,383
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.